Canary Capital Group has filed a revised S-1 form with the U.S. SEC for its proposed Canary XRP ETF. This move is viewed as ...

Canary Capital amends S-1 for XRP ETF, raising approval hopes as lawsuit dismissal boosts confidence in Ripple’s regulatory ...

Regarding the price impact of an ETF decision, Finbold turned to ChatGPT-5, which stressed that approval could propel the ...

Canary Capital, an investment firm specializing in cryptocurrency ETFs, has made a move hinting at rising institutional ...

Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors. Gold hit record highs of close to US$2800/oz ...

Canary Capital CEO predicts XRP ETFs will outperform ETH ETFs, as the SEC confirms the XRP lawsuit end, boosting hopes for a ...

As the Ripple vs. Securities and Exchange Commission (SEC) case reached its final stage, spot exchange-traded funds (ETFs) ...

Canary Capital registers a new Trump Coin ETF in Delaware, signaling growing interest in memecoin ETFs under friendlier US ...

Canary Capital gives Bio a discounted cash flow valuation of $0.66 a share and an equity valuation of $126.2 million – up from the current market cap of $48.75 million.

Canary Capital gives Bio a discounted cash flow valuation of $0.66 a share and an equity valuation of $126.2 million – up from the current market cap of $48.75 million.

Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors. Gold hit record highs of close to US$2800/oz ...